Sophie Ducastelle

Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units

O. Maison, Cléa Tardy, Delphine Cabelguenne et al. · European Journal of Clinical Pharmacology · 2018 · 51 citations

Medicine, Hematology, Pharmacology +15

Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients

Mauricette Michallet, Thomas Bénet, Mohamad Sobh et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2011 · 45 citations

Medicine, Hematology, Oncology +16

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia

Adriana Pleșa, Charles Dumontet, Eve Mattei et al. · World Journal of Stem Cells · 2017 · 36 citations · Full text

Medicine, Hematology, Oncology +17

The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge

Franck E. Nicolini, Jean‐Claude Chomel, Lydia Roy et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 35 citations

Medicine, Pharmacokinetics, Pharmacology +11

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens

Marie Y. Detrait, Valérie Dubois, Mohamad Sobh et al. · Experimental Hematology · 2012 · 31 citations

Medicine, Hematology, Immunology +14